Cargando…
The Efficacy of S-1 as Adjuvant Chemotherapy for Resected Biliary Tract Carcinoma: A Propensity Score-Matching Analysis
Even though S-1 is a widely used chemotherapeutic agent, there is no evidence for its use in an adjuvant setting for biliary tract carcinoma (BTC). Patients who underwent surgical treatment for BTC between August 2007 and December 2018 were selected. Propensity score matching was performed between p...
Autores principales: | Miyata, Yoichi, Kogure, Ryota, Nakazawa, Akiko, Nagata, Rihito, Mitsui, Tetsuya, Ninomiya, Riki, Komagome, Masahiko, Maki, Akira, Kawarabayashi, Nobuaki, Beck, Yoshifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957643/ https://www.ncbi.nlm.nih.gov/pubmed/33804297 http://dx.doi.org/10.3390/jcm10050925 |
Ejemplares similares
-
Left hepatic trisectionectomy for hilar cholangiocarcinoma presenting with an aberrant biliary duct of segment 5: a case report
por: Akamatsu, Nobuhisa, et al.
Publicado: (2010) -
Sex differences in postsurgical skeletal muscle depletion after donation of living-donor liver transplantation, although minimal, should not be ignored
por: Nagata, Rihito, et al.
Publicado: (2020) -
Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
por: Matsubara, Nobuaki, et al.
Publicado: (2013) -
Adjuvant treatments for biliary atresia
por: Burns, Jessica, et al.
Publicado: (2020) -
Endoscopic Ultrasound-Guided Biliary Drainage for Benign Biliary Diseases
por: Nakai, Yousuke, et al.
Publicado: (2019)